Current Status and Quality Improvement Strategy in in vitro Diagnostic Reagents Clinical Trials of Medical Device Clinical Trial Institutions in Shandong Province

Liu Shanshan, Zhang Yunjuan, Wang Jian, Dong Dandan

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (9) : 1018-1025.

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (9) : 1018-1025. DOI: 10.16153/j.1002-7777.2022.09.007
Quality Management

Current Status and Quality Improvement Strategy in in vitro Diagnostic Reagents Clinical Trials of Medical Device Clinical Trial Institutions in Shandong Province

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 36(9): 1018-1025 https://doi.org/10.16153/j.1002-7777.2022.09.007

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/